Prolonged Pemetrexed Maintenance (42 Cycles over 34 Months) in Metastatic Lung Adenocarcinoma: Durable Disease Control and Progressive Renal Impairment—A Case Report
Journal of Cancer Therapy · 2026 · 17 (11) · 566-578
DOI: 10.4236/jct.2026.1711047 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Cancer Therapy, 2026. Verfasst von Maryem Agaraoui und 6 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Agaraoui, M., Abbassi, M. B., Amaadour, L., Oualla, K., Benbrahim, Z., Arifi, S., & Mellas, N. (2026). Prolonged Pemetrexed Maintenance (42 Cycles over 34 Months) in Metastatic Lung Adenocarcinoma: Durable Disease Control and Progressive Renal Impairment—A Case Report. Journal of Cancer Therapy, 17(11), 566-578. https://doi.org/10.4236/jct.2026.1711047
Vancouver
Agaraoui M, Abbassi MB, Amaadour L, Oualla K, Benbrahim Z, Arifi S, et al. Prolonged Pemetrexed Maintenance (42 Cycles over 34 Months) in Metastatic Lung Adenocarcinoma: Durable Disease Control and Progressive Renal Impairment—A Case Report. Journal of Cancer Therapy. 2026;17(11):566-578. doi:10.4236/jct.2026.1711047
BibTeX
@article{Agaraoui2026,
author = {Agaraoui, Maryem and Abbassi, Mounir Belcadi and Amaadour, Lamyae and Oualla, Karima and Benbrahim, Zineb and Arifi, Samia and Mellas, Nawfel},
title = {Prolonged Pemetrexed Maintenance (42 Cycles over 34 Months) in Metastatic Lung Adenocarcinoma: Durable Disease Control and Progressive Renal Impairment—A Case Report},
journal = {Journal of Cancer Therapy},
year = {2026},
volume = {17},
number = {11},
pages = {566--578},
doi = {10.4236/jct.2026.1711047}
}
EUVIMED